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Abstract
Infections by oral pathogens are one of themost commonhealth problemsworldwide. Due to the
intimate connection between exhaled breath and the oral cavity, breath analysis could potentially be
used to diagnose these infections. However, little is known about the volatile emissions of important
oral pathogens that are connectedwith gingivitis and periodontitis. In this study, we have performed
in vitro headspacemeasurements on four important oral pathogens (P. gingivalis, T. forsythia, P.
intermedia andP. nigrescens)using proton transfer reaction time-of-ﬂightmass spectrometry (PTR-
TOF-MS). Some of themost abundant compounds produced by the bacteria include hydrogen
sulphide,methanethiol, acetone, dimethylsulphide, isoprene, cyclopentanone and indole as
tentatively assigned from themass spectra. Several other abundantmass signals were recorded but the
assignment of these is less certain. Some of the bacterial species can be separated from each other by
the emitted volatile ﬁngerprints. The results of this study can be used in potential development of a
diagnostic breath test for oral infections. In addition, as several of themeasured compounds are
known to be toxic, the results point to an intriguing possibility of studying the connection between the
bacterial virulence and the emitted volatile compounds.
1. Introduction
The number of bacterial species present in the human
mouth is estimated to be somewhere between 500 and
700 [1, 2]. Exhaled breath is directly connected with
the oral cavity, where these oral microorganisms can
produce signiﬁcant amounts of volatile compounds.
Oral infections are some of themost common diseases
worldwide, with over 11% of the whole adult popula-
tion having severe periodontal disease [3], and about
30% of elderly people having no natural teeth [4].
Nevertheless, this obvious diagnostic application has
been mostly neglected by the exhaled breath commu-
nity, with the exception of sulphur containing com-
pounds and the diagnostics of halitosis [5–10].
Volatiles produced by other human pathogenic
bacteria, such as Pseudomonas aeruginosa,Mycobacter-
ium tuberculosis and Helicobacter pylori, have been
studied extensively in recent years [11, 12], but
comprehensive reports of oral bacteria and the vola-
tiles they produce are scarce. Volatiles originating
from the oral cavity have been mainly considered as a
hindrance for breath analysis [13–15], andmany of the
possibilities they provide have been overlooked. How-
ever, some recent publications speciﬁcally concentrate
on the volatile compounds produced by oral patho-
gens, and the usage of those compounds as biomarkers
[16–18]. The analysis of volatile organic compounds
(VOCs) for faster and easier screening of infections has
also been a subject of growing interest in general [19].
Sensitive and speciﬁc breath biomarkers for oral
pathogens could represent a major breakthrough
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in the non-invasive diagnostics of oral infections
and decrease the yearly economic burden of over
400 billionUSD consumed by oral diseases [3].
Most of the adult population around the world
have some inﬂammation of the gum tissue, known as
gingivitis [20, 21]. When the numbers of anaerobic,
Gram-negative, rod-shaped bacteria and spirochetes
increase compared to the other bacteria in the sub-
gingival plaque, gingivitis is more likely to occur [22].
These bacteria utilize the gingival tissue for nutrients
and produce compounds that irritate and destroy it.
The bacteria and the degradation of the gingival tissue
cause immune response, which can lead to more ser-
ious damage as the surrounding tissue detaches from
the tooth. Consequently, the plaque on the tooth sur-
face grows further below in the developing period-
ontal pockets and causes more inﬂammation. The
bacteria in the subgingival plaque together with heigh-
tened immune response cause further destruction of
the periodontal ligaments, and eventually alveolar
bone is permanently destroyed [23, 24]. At this point
gingivitis has developed into periodontitis, a destruc-
tive diseasewith irreversible effects.
It has been established that the risk for developing
periodontitis partly depends on the kinds of bacteria
present in the subgingival plaque [22, 25]. Tradition-
ally, these oral bacteria have been placed in colour-
designated complexes based on their likelihood of
causing periodontitis and their association with each
other [26, 27]. Red complex bacteria impose a high
risk for periodontitis and are strongly co-operative
with each other. Orange and yellow complex bacteria
are connected to moderate and low risk of period-
ontitis, respectively. However, in the recent years this
colour-complex grouping has been criticized to be an
over-simpliﬁcation, and some new bacterial species
have been connected to the development of period-
ontitis. The dominance of gram-negative bacteria as
major pathogens for periodontitis over gram-positive
species has also been reassessed [28]. Nevertheless, in
this study, our focus was on the red and orange com-
plexes, and the bacteria traditionally thought to cause
the highest risk for periodontitis. Red complex bac-
teria include Porphyromonas gingivalis, Tannerella for-
sythia, and Treponema denticola. Orange complex
bacteria include Fusobacterium nucleatum, Prevotella
intermedia, Prevotella nigrescens, Parvimonas micra,
Eubacterium nodatum, and various Campylobacter
species [26]. For this study, we chose two representa-
tive species from both complexes: P. gingivalis, T. for-
sythia, P. intermedia and P. nigrescens. In addition, we
chose three different strains of P. gingivalis to investi-
gate the differences in volatile biomarkers between dif-
ferent strains of the same species.
Despite its global prevalence, periodontal disease
is often left untreated, because of high costs and poor
availability of dental care in some regions [29, 30]. In
addition, periodontal disease has been connected to
several other highly prevalent conditions, such as
diabetes mellitus, cardiovascular diseases, the human
immunodeﬁciency virus (HIV) and Alzheimer’s dis-
ease [31–35]. Early diagnosis and treatment can
decrease the probability of gingivitis developing into
periodontitis, and consequently, increase the well-
being of the patient as well as reduce the time and cost
of the recovery. VOCs produced by the oral bacteria
could be used as biomarkers for oral infections, and
they could aid in the identiﬁcation of bacterial species
present in the oral cavity. Microbial VOCs could also
help us to better understand the virulence factors,
metabolic processes, signalling, and bioﬁlm formation
of bacteria, as well as the tissue damage they are
involved in during periodontitis. In this study, we
measured the volatile in vitro ﬁngerprints of some of
the major pathogenic bacteria connected to period-
ontitis. Volatiles produced by the bacteria were mea-
sured with proton transfer reaction time-of-ﬁghtmass
spectrometry (PTR-TOF-MS). We also aimed to ten-
tatively identify the produced VOCs and evaluate their
potential as volatile biomarkers for the studied
pathogens.
2.Materials andmethods
2.1. Bacterial strains and culturingmethod
Bacterial strains used in this study were: P. gingivalis
ATCC 33277, P. gingivalis ATCC 53978 (W50),
P. gingivalis OMG 434, P. intermedia ATCC 25611,
P. nigrescens ATCC 35563, and T. forsythia ATCC
43037. With the exception of P. gingivalis OMG 434
from the Gothenburg Culture Collection, all other
strains were obtained from American Type Culture
Collection (ATCC).
All the strains were stored at −80 °C in frozen
skim milk. Strains were activated by streaking onto
Brucella blood agar (BBLTM, 211086) plates, supple-
mented with horse blood (5% v/v), hemin (5 mg l−1)
and vitamin K1, except T. forsythia ATCC 43037,
which was cultured on tryptic soy agar (TSA), with
n-acetylmuramic acid and sheep blood. All bacterial
strains were incubated in anaerobic gas mixture (5%
CO2, 10% H2 and 85% N2) at 37 °C for 72 to 120 h.
After the incubation, 3.0 ml of phosphate-buffered
saline (PBS) was pipetted onto the agar plate, bacteria
were gently scraped from the agar, and transferred into
a FalconTM tube. This bacterial suspension was homo-
genized by gently pipetting. The initial amount of bac-
teria in the suspensions used ranged between 1.0 and
4.0×107 colony forming units (CFUs) per ml. From
the 3.0 ml of bacterial suspension, 0.250 ml was pipet-
ted onto a new agar plate, which was placed in an air-
tight headspacemeasurement container. Triplicates of
each bacterial strainwere prepared.
2.2. Bacterial headspacemeasurements
Our custom-built sampling line is fully automated and
able to supportup to sixbacterial cultures simultaneously.
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The sampling line enables both continuous and one-
point measurements of the headspace gas. Figure 1(a)
describes our custom-build containers for bacterial head-
space measurements. The main body of these containers
is made from stainless steel, and the lid from polycarbo-
nate. The ﬁttings between the containers and the
sampling line are stainless steel (Swagelok®). The ﬁlters
used in the containers are syringe ﬁlters (Sterile Millex®,
Merck Millipore) with 0.22μm pore size. During the
measurements, containers are kept in an incubator at
37 °C.The total volumeofone container is 300ml.
The full sampling system used for the headspace
measurements is described in ﬁgure 2. Most of the
sampling line is composed of inert polytetra-
ﬂuoroethylene (PTFE) tubing. Cold traps are placed
outside the incubator to collect excess moisture pro-
duced by the bacterial cultures, and to prevent it from
condensing to the sampling line downstream or inside
the instrument. The cold traps used consist of a stain-
less steel three-way ﬁtting (Swagelok®) and a small
container for condensed water. Cold traps used are
described in ﬁgure 1(b). Two six-way valves (080T6
Figure 1. (a) Schematic representation of the bacterial container designed for bacterial headspacemeasurements. The pressure inside
the container ismonitored. The containers are suitable for both aerobic and anaerobic culturing.With anaerobic bacteria, excess
oxygen is removedwith a palladium catalyst placed in the container. Bacterial ﬁlters placed on inlet and outlet are used tominimize
contamination to and from the sampling line. Distilled, sterilizedwater on the bottomof the container is used to humidify the
headspace and prevent bacterial cultures fromdrying. (b) Schematic representation of the cold traps used in the sampling line.When
warmheadspace gas from the bacterial containers ﬂows through the PTFE tubing (in light grey) and the three-way ﬁtting (in dark
grey), kept at room temperature,moisture condenses and drips downwards into thewater collector. The headspace gas, with excess
moisture removed, ﬂows further into themeasurement instrument.
Figure 2. Schematic representation of the automated sampling and PTR-TOF-MSmeasurement system for volatiles emitted by
bacterial cultures. This system supports up to six cultures—aerobic or anaerobic. Grey lines indicate PTFE tubing and black lines
signal cables. CT refers to cold traps used for collecting condensedwater, andDAQ to a data acquisition card. Two six-way valves are
used for the selection of containers, and this valve control is fully automated.
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series Flow Selection Valve, Bio-Chem ValveTM) with
PTFE bodies, are used to control the ﬂow of gas in and
out of containers. These valves are connected to the
PTR-TOF-MS and controlled with the measurement
program of the instrument (IoniTOF, Ionicon). The
valves can be programmed to open and close auto-
matically. Amass ﬂow controller is used to regulate the
ﬂow of the carrier gas from the bottle to the sampling
line. For the online measurements of bacterial cul-
tures, this ﬂow is kept at 20 ml min−1. Pressure inside
the bacterial containers was recorded and controlled
to be approximately 1 bar (=105 Pa) during the
measurements.
In our measurements, three out of the six possible
bacterial containers were used simultaneously. Bacter-
ial headspace from each container was successively
sampled for 20 min, with a continuous gas ﬂow of
20 ml min−1 directed through the container. During
this 20 min period, the spectrum and concentrations
were monitored. The concentrations were allowed to
reach a steady state at around 18 min. The last 2 min of
the data was considered to represent the true composi-
tion of the headspace at the time, and was averaged as
an hourly measurement point. During the measure-
ment of the two other containers (40 min), the gas
ﬂow to the container was stopped. The 60 min cycle
(3×20 min)was repeated 160 times.
2.3. PTR-TOF-MS instrument
PTR-TOF-MS is an online mass spectrometry techni-
que, which uses chemical ionization to enable the
measurements of individual VOCs ranging from
parts-per-million (ppm, 10–6) down to parts-per-
trillion (ppt, 10–12) levels. Sample compounds are
ionized via proton transfer reactions with H3O
+ ions,
and therefore the resulting sample ions are detected
one atomic mass unit higher than the molecular
weight of the neutral equivalents. Successful proton
transfer reaction requires the sample molecule to have
higher proton afﬁnity than water, which does not
allow reliable measurement of some volatile com-
pounds, such as CO2 and CH4. This limitation can be
overcome by changing the precursor ion to NO+ or
O2
+. The measurements in this study were conducted
with H3O
+. A separate sensor for CO2 (Vaisala,
GMP251) was used. A commercially available PTR-
TOF-MS instrument (PTR-TOF 1000, Ionicon) was
used for all measurements. This instrument uses the
TOF method for analysing the ions after ionization.
The speciﬁed mass resolution of the instrument is
1500m/Δm (full-width at half-maximum).
PTR-TOF-MS is a direct mass spectrometry
method, and it is unable to distinguish isobaric com-
pounds nor structural isomers from each other. Con-
sequently, the identiﬁcation of VOCs responsible for
speciﬁc peaks in the mass spectrum is difﬁcult, when
several compounds with the same nominal mass,
but different exact mass, are present. Identiﬁcation
of compounds can further be complicated by frag-
mentation of product ions and water clustering.
Because PTR-TOF-MS does not provide direct struc-
tural identiﬁcation of signals, additional measure-
ments with pure reference samples were carried out to
help identify some of the VOCs. All reference samples
were obtained fromSigma-Aldrich®.
Mass scans were performed from mass-to-charge
ratio (m/z) 17 to 239. PTR-TOF-MSoperating conditions
were as follows: ﬁeld density ratio (E/N) of 127 Td; drift
tube pressure of 2.20 mbar, H2O ﬂow of 5.0 standard
cubic centimetres per minute (sccm); ion source current
of 3.0mA; inlet ﬂow of 20 sccm and drift tube voltage of
551 V. Drift tube and inlet temperatures were kept at
70 °C. Sampling frequency was 1Hz, meaning one spec-
trumwas recorded every second.
3. Results
Tentative identiﬁcation of the compounds produced
by the bacteria was aided by measuring the spectra of
pure reference substances. Nitrogen gas was directed
through a test tube containing the reference substance,
and spectrum was measured from the headspace gas
with the PTR-TOF-MS instruments. Spectra were
recorded for single headspace concentration of each
reference sample. Based on fragmentation patterns in
the reference spectra and literature references, we offer
tentative identities for some of the most interesting
signals produced. Correlations between the fragment
concentrations and assumed original compounds
were also assessed to further verify the connection.
However, measurements of the reference samples and
the analysis of resulting spectra was rudimentary, and
the main motivation was to gain additional aid in the
tentative identiﬁcation of the signals. Information
from the reference spectra was always used alongside
literature references from earlier research. Absolute
identiﬁcation of the produced compounds requires
further analysis, for example, by gas chromatography-
mass spectrometry (GC-MS).
Figures 3(a)–(c) presents an example of the frag-
ment analysis done in order to identify some of the
compounds. Additional fragmentation spectra are
included in the supplementary information, which is
available online at stacks.iop.org/JBR/14/016010/
mmedia. It should be noted that the humidity level in
the referencemeasurements was lower than in the bac-
terial headspace, which can have a signiﬁcant effect on
the fragmentation pattern.
In the headspace measurements, several compounds
were found to be emitted by the bacteria, some of
which were clearly indicative of certain bacterial
species. Table 1 lists the mass-to-charge ratios and
concentrations of those compounds we found to have
the largest potential as volatile biomarkers for oral
bacteria. Concentrations of the compounds produced
by the bacteria are further illustrated by a bar graph in
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ﬁgure 4. These compounds are either solely speciﬁc for
certain bacterial species, or produced by multiple
bacteria, but considered in our opinion to be interest-
ing. Concentrations listed are the maximum values of
the dynamic production proﬁles, examples of which
are presented in ﬁgures 5(a)–(f). The dynamic produc-
tion proﬁles describe the compound concentrations
produced by the bacteria as a function of time. Note
that the place of the maxima can vary between
compounds and different bacterial species as well as
according to how a speciﬁc culture is growing.
Example spectra recorded for each bacterial species, as
well as, additional dynamic production proﬁles are
included in the supplementary information. All com-
pounds considered to be potential biomarkers were
produced by the bacteria in clearly distinct levels
compared to the empty agar background. The
dynamic production proﬁles for all of these com-
pounds also showed resemblance to the general
bacterial growth curve, with a clear exponential phase
and amaximumproduction.
The PTR-TOF-MS instrument was not speciﬁcally
calibrated for the analysed compounds. Therefore, the
concentrations presented in this study are estimates.
The aim of this study was predominantly to investigate
the kinds of compounds the orange and red complex
oral bacteria are able to produce. Quantiﬁcation was
not our primary concern. However, the concentrations
were reasonably similar between the triplicatemeasure-
ments, so we are conﬁdent that the concentrations
reported are reasonably precise. In the future, accurate
concentrations can be achieved by calibrating the PTR-
MS systemwith each compound separately. The culture
conditions and the amount of bacteria effect the pro-
duction levels drastically, and therefore, we aimed to
keep them constant during our measurements. Fur-
thermore, nutrient agars produce a large number of
compounds, which was acknowledged by considering
agar production as a background in the bacterial
measurements.
4.Discussion
We considered 13 of the signals produced to be
potential biomarkers:m/z 35, 49, 57, 59, 63, 69, 71, 85,
87, 91, 95, 101, and 118. Several of these compounds
were produced by all of the bacterial species studied.
However, the levels at which they were produced
varied signiﬁcantly between different bacteria. These
volatiles could be used in the future to identify the
studied oral pathogens. Although, differentiating
between the bacteria according to their volatile
ﬁngerprints should be further conﬁrmed, with mea-
surement of mixed cultures as well as blinded experi-
ments.Many of the other compounds produced by the
bacteria can be considered as common, and more
importantly, have been identiﬁed to be a part of
the normal composition of human exhaled breath.
Some of them have also been found from the volatile
ﬁngerprint of microbes unrelated to periodontitis, but
Figure 3. (a)–(c)An example of a referencemass spectrumof a pure compound and a correspondingmass spectrumof a headspace
bacterialmeasurement. In this case, the reference spectrumof isoprene gives a better correspondence to the bacterial headspace
spectrum than furan, and therefore, isoprene is themore probable origin for the signal atm/z 69. Fragment ion (C5H9
+) from larger
compounds, such as certain aldehydes, alcohols and alkenes, can also contribute to this signal. In fact, the bacterial spectra ofP.
gingivalisW50 shows an ion series (m/z 41, 55, and 69) characteristic for E-2-hexenal, which could indicate contribution from this
compound.
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Table 1.Most prominent volatiles emitted by the oral anaerobes. Values are expressed as in ppbmean±standard deviation (N=3) of themaxima of the dynamic production proﬁles described in ﬁgures 5(a)–(f). Note that the place of the
maxima can differ between different compounds and bacterial species, as can be observed from the production proﬁles. Some of the compoundswere tentatively identiﬁed (in bold)with fragmentation patterns and references from
literature.
m/z
P. gingivalisATCC
33277 P. gingivalisW50
P. gingivalis
OMG434
P. intermedia
ATCC25611
P. nigrescensATCC
35563
T. forsythiaATCC
43037
Brucella horse
blood agar
Tyrptic soy sheep
blood agar
35.00Hydrogen sulphide 31±7.6 31±11 13±1.2 26±5.0 22±1.3 1.0±0.3 0.4±0.01 1.5±0.1
49.01Methanethiol 2969±475 3561±332 2284±231 26±4.3 55±6.3 30±10 6.1±0.9 3.8±0.2
57.03Butene, Acrolein 280±6.2 68±25 62±29 22±3.1 29±0.4 6.6±0.9 2.5±0.3 1.0±0.01
59.05Acetone 1647±262 1648±595 1220±646 155±43 211±76 31±1.5 26±5.8 30±6.0
63.03DMS 11±3.9 18±8.0 19±0.7 6.9±2.3 18±1.1 3.1±0.1 5.3±0.8 5.0±0.4
69.03 Isoprene, fragment ion (C5H9
+) 23±5.3 237±19 115±75 258±20 1897±263 7.2±0.9 5.4±0.1 5.8±0.2
71.05Pentene/Isopentene, crotonaldehyde 76±3.8 72±7.8 161±94 127±12 139±16 100±17 1.3±0.3 1.3±0.1
85.06Cyclopentanone 5.5±0.7 14±5.7 11±3.8 3.6±0.5 5.3±0.4 0.8±0.1 0.5±0.02 0.4±0.03
87.04Pentanone/methyl butanal, diacetyl,
methyl butenol
20±1.0 26±2.7 33±2.8 62±5.0 468±85 2.5±0.2 2.6±0.1 2.6±0.2
91.04Butanethiol,methylthiourea, tropy-
lium ion/other fragment ion (C7H7
+)
5.4±2.1 11±5.4 11±1.6 2.2±0.2 4.8±0.5 1.3±0.01 1.6±0.3 1.0±0.1
95.05DMDS, phenol, fragment ion (C7H11
+ ) 24±11 36±6.9 34±16 0.6±0.4 3.0±1.0 1.8±1.0 1.1±0.2 0.3±0.03
101.06Hexanal, acetyl acetone,MIBK 6.0±0.6 5.5±0.7 4.3±0.9 3.2±0.4 4.3±0.4 3.5±0.9 2.1±0.1 1.2±0.1
118.07 Indole, benzyl cyanide 37±6.5 26±2.5 40±5.4 51±3.2 55±4.1 6.4±0.2 7.0±0.9 1.8±0.02
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present in the oral cavity. Consequently, these com-
pounds are not ideal considering breath biomarkers
for oral infections, because they can originate from
other sources. Such compounds are for example
methanol, ethanol, and acetoacetic acid, which were
not considered further in this study. The possible
identities of the biomarker signals and the production
levels according to bacterial species are discussed next.
The signal at m/z 49 is one of the most prominent
peaks in the mass spectra, especially for P. gingivalis.
This peak was assigned to methanethiol (CH4S) based
on reference spectra comparison and because metha-
nethiol production of P. gingivalis has been conﬁrmed
in earlier studies [6, 36–38]. Methanethiol, also known
as methyl mercaptan, is produced by some human
pathogenic bacteria, including P. gingivalis, T. denti-
cola, F. nucleatum, Citrobacter freundii, Staphylococcus
aureus, P. aeruginosa, Streptococcus pneumoniae and
Haemophilus inﬂuenzae, mostly by enzymatic degra-
dation of L-methionine [38–41]. Most of the patho-
genic bacteria capable of producing methanethiol are
related to oral infections, and its pungent smell is
thought to be the main culprit in halitosis [6, 8–10]. It
is also produced by several pathogenic species present
in small amounts in the microbiota of the respiratory
tract [40, 41]. Methanethiol is a toxic compound, and
the general health effects of exposure by inhalation are
well known. The long-term effects on cells and tissues
are still mostly unclear, but it has been suggested that
methanethiol may contribute to the pathogenesis of
periodontitis [6, 37, 42, 43]. In this study, we report
the concentrations produced by three different P. gin-
givalis strains (33277, W50 and OMG 434) to be
several ppm (3.0, 3.5 and 2.0). These amounts are sig-
niﬁcant, considering that the occupational exposure
limit of inhaled methanethiol is 0.5 ppm. The levels of
methanethiol produced by P. gingivalis are most likely
not as high in the oral cavity, because of the less ideal
growing conditions and the smaller number of bac-
teria. However, considering that the exposure to bac-
terial volatiles in the oral cavity is continuous and
long-term, the possible effects on oral health cannot be
ignored. Concentrations of methanethiol measured
from the human exhaled breath vary between 0 ppb
and 40 ppb for healthy subjects and between 0 ppb and
around 700 ppb for people with halitosis [8, 9]. These
levels are considerably lower than the maximum pro-
duction capacity of P. gingivalis. The trend of metha-
nethiol production between the different P. gingivalis
strains are consistent with previous studies, with larger
production from the more virulent W50 strain than
from the others [36–38]. Other bacterial species cap-
able of producing methanethiol could hinder its usage
as a biomarker for oral infections. However, the levels
of methanethiol produced in our culture model by all
P. gingivalis strains are 10 to 100 times larger than pre-
viously reported for bacterial species of the respiratory
tract [40, 41].
Several of the compounds produced by the studied
oral bacteria have a distinct smell. The signal atm/z 63
is tentatively assigned to dimethyl sulphide (DMS,
C2H6S) and the signal at m/z 35 to hydrogen sulﬁde
(H2S), according to inspection of reference spectra and
literature [43–45]. Both of these sulphur-containing
compounds have an unpleasant smell, and therefore,
are among the main culprits in halitosis [6, 8–10, 42].
Figure 4.Description of the 13 signalsmost potential as biomarkers for speciﬁc oral bacteria, or for pathogenic oral infections in
general. Signals atm/z 49, 59, 95 and 57 are produced in larger amounts by P. gingivalis than by the other three bacteria. Signals atm/z
69 and 87 are produced in larger amounts by P. nigrescens andP. intermedia.T. forsythia produces signiﬁcantly less compounds and in
lower levels than the other bacteria, however, production of signals atm/z 49, 71 and 101 reach levels comparable to those of the other
species. Some signals, such asm/z 35 andm/z 118 are produced in similar levels bymost of the bacteria.
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In addition to oral bacteria, DMS has also been mea-
sured from the headspace of several other human
pathogenic bacteria in levels varying from a few ppb to
some hundreds [40, 41]. Concentrations in the human
exhaled breath of healthy people vary between 0 and
30 ppb for DMS, and between 0 and 70 ppb for hydro-
gen sulﬁde. However, in people with halitosis the con-
centrations can increase up to 50 ppb and 700 ppb,
respectively [9]. In our study, P. gingivalis and P.
nigrescens produced varying levels of these sulphur
containing compounds. P. intermedia and T. forsythia,
on the other hand, either produced them in very small
amounts or not at all. P. gingivalis andP. nigrescens also
produced these sulphur compounds in levels higher
than the odour detection limit for humans. It should
be noted, however, that the concentrations of both
compounds produced by the selected bacteria are
lower than the concentrations in human exhaled
breath and those measured from some human patho-
genic bacteria of the respiratory tract [40, 41]. This
Figure 5. (a), (b)Dynamic production proﬁles ofm/z 35 (hydrogen sulphide) andm/z 49 (methanethiol). Colour coding of the
different bacteria is same in both dynamic production proﬁles. Each data point represents the hourlymean value. Error bars indicate
the standard deviation of triplicatemeasurements. (c), (d)Dynamic production proﬁles form/z 95 andm/z 87. Colour coding of the
different bacteria is same as in theﬁrst production proﬁle (5a). Each data point represents the hourlymean value. Error bars indicate
the standard deviation of triplicatemeasurements. (e), (f)Dynamic production proﬁlesm/z 101 andm/z 71. Colour coding of the
different bacteria is same as in theﬁrst production proﬁle (5a). Each data point represents the hourlymean value. Error bars indicate
the standard deviation of triplicatemeasurements.
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indicates that there are other sources for these com-
pounds in the exhaled breath in addition to the oral
bacteria studied here. DMS and hydrogen sulﬁde,
together with methanethiol, seem to be some of the
most important volatiles for the studied bacteria, and
their functions beyond halitosis should be further
investigated. Their long-term effects to the oral cavity
and gingival tissue should not be overlooked either. It
has been shown in earlier studies that the ratio of
hydrogen sulphide and methanethiol in exhaled
breath could be an indicator of the periodontal stage,
with the increased amount of methanethiol compared
to hydrogen sulphide suggesting progressed period-
ontal disease [8, 43]. This trend might suggest that the
amount of P. gingivalis, the most important producer
of methanethiol, is signiﬁcantly increased compared
to the other microbes in patients with periodontitis. It
has also been shown that the concentrations of metha-
nethiol are increased compared to hydrogen sulphide
in the microenvironment of the gingival pockets [42].
DMS or hydrogen sulﬁde originating from the oral
cavity can hinder the usage of these compounds as
breath biomarkers for other diseases. For example, it
has been reported that DMS could be a non-species-
speciﬁc marker for bacterial presence in patients suf-
fering from ventilation-associated pneumonia (VAP)
[46]. Increased concentrations of DMS in the alveolar
breath have also been connected to liver disease due to
the insufﬁcient metabolism of the sulphur-containing
amino acids [47]. As oral bacteria can signiﬁcantly
affect the concentrations measured from the human
exhaled breath, the contribution from the oral cavity
should be acknowledged, when developing breath
analysis for diagnostic purposes.
The signal atm/z 85 is tentatively assigned to cyclo-
pentanone (C5H8O) based on the reference spectra
and references from literature [44, 48, 49]. It has a
pleasant smell, with no determined exposure limits or
hazardous health effects. Its cytotoxicity, which is an
important aspect considering tissue damage in oral
infections, is also largely unknown. It has been sug-
gested that cyclopentanone is produced from furfural
(furan-2-carbaldehyde, C5H4O2) by enzymatic degra-
dation, and at least Escherichia coli and P. aeruginosa
are capable of producing it [44, 49]. However, the bio-
logical role of cyclopentanone is unclear. Furfural is a
genotoxic compound, and therefore, bacterial cells
aim to convert it into something less toxic, such as
cyclopentanone [49]. Thus, cyclopentanone produc-
tion by the oral bacteria studied here could also be
linked to furfuralmetabolism. A small signal from fur-
fural is found at m/z 97 in the bacterial spectra, and
there is a strong positive correlation (R=0.92)
between the signals atm/z 85 and 97. This further sug-
gests a connection between cyclopentanone produc-
tion and furfural metabolism. The levels of
cyclopentanone produced by the bacteria studied are
low.T. forsythia does not producing it above the empty
culture plate level. P. gingivalis seems to produce
higher levels of cyclopentanone than P. intermedia and
P. nigrescens. In addition, two of the P. gingivalis
strains, OMG 434 and W50, produce larger amounts
than the ATCC 33277 strain. The differences in the
volatile ﬁngerprints of different strains of the same
species introduce a possibility for even more speciﬁc
identiﬁcation of pathogens. It should be noted that
other compounds, with the formula C5H8O, as well as
some fragment ions, are also possible contributors for
the signal at m/z 85. However, previous reports on
bacterial emissions of these volatiles are scarce com-
pared to those of cyclopentanone [44, 48, 49]. These
literature references, together with the measurements
done with reference samples, lead us to our tentative
conclusion about the identity of the signal.
The signal atm/z 69 ismost likely produced by iso-
prene (2-methylbuta-1,3-diene, C5H8) according to
reference spectra and literature. Most of the biological
isoprene is produced by plants and algae, however,
several water, soil, and human pathogenic bacteria are
also known to produce it [44, 48, 50, 51]. To our
knowledge, production of isoprene by oral bacteria
has not been reported earlier. It has been suggested
that isoprene could be a signalling molecule, in addi-
tion to being a by-product of nutrient usage [50, 51].
There is also evidence of isoprene production being a
protective stress response to toxins and temperature
change, as seen in plants [51]. Isoprene is also found
from the human exhaled breath, with concentrations
ranging from a few ppb to several hundred [52]. This
canmake the usage of isoprene as a biomarker for oral
infections difﬁcult, because the true origin of the com-
pound in breathmay be hard to determine. Isoprene is
produced abundantly by P. gingivalis strains OMG434
and W50, P. intermedia and P. nigrescens. P gingivalis
strain ATCC 33277 and T. forsythia produce lower
levels of this compound. P. nigrescens produces iso-
prene in signiﬁcantly higher levels (>1000 ppb) than
the other bacteria, which makes this compound a
potential marker especially for P. nigrescens. There are
also some differences in the place of the production
maxima between different bacterial species. P. nigres-
cens and P. intermedia produce isoprene during the
whole of the active growth phase with production
maxima around 60 h, whereas P. gingivalis starts to
produce isoprene at a signiﬁcantly later time-point
with maxima at around 100 h. This might be an indi-
cation of dissimilar biological functions of isoprene
for different bacteria. The production of isoprene by P.
gingivalis during the late stationary and death phases
might indicate stress response, whereas production
during the active growth could be connected to signal-
ling or bioﬁlm formation. This has been suggested
brieﬂy in an earlier publications [53], but any empiri-
cal proof is lacking. Another possibility for signal atm/
z 69 is a fragment ion (C5H9
+) originating from larger
compounds, such as methylbutanal or methylbutenol
(C5H10O), methyl isobutyl ketone (MIBK, C6H12O),
some monoterpene, alkene or aldehyde. There is no
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correlation between the signal atm/z 69 and atm/z 101
(possibly MIBK). However, there is a strong positive
correlation (R=0.99) between m/z 69 and m/z 87
(possibly methylbutanal or methylbutenol). There is
no evidence for monoterpene production by the bac-
teria at m/z 137. However, several bacterial spectra
show an ion series (m/z 41, 55, and 69) characteristic
for certain aldehydes, such as E-2-hexenal. It is likely
that the signal atm/z 69 originates from the combina-
tion of isoprene and theC5H9
+ fragment ion.
The signal at m/z 59 is most likely acetone (pro-
pan-2-one, C3H6O), based on the reference spectra.
Several anaerobic bacteria, referred to as acetogens, are
known to produce acetone [48, 54] by the ﬁxing of
CO2 and the production of acetyl coenzyme A (CoA)
[54]. However, only a few bacteria connected to the
humanmetabolism have been identiﬁed as acetogenic.
Acetone is also a naturally occurring volatile in the
human exhaled breath, originating from the forma-
tion of acetyl-CoA from fatty acids in the liver [55].
According to our results, the studied oral bacteria are
able to produce high amounts of acetone on culture
plates, which to our knowledge is a novel ﬁnding.
Acetone in human exhaled breath has been one of the
major areas of research in the ﬁeld of breath analysis,
and its usage as a breath biomarker especially for dia-
betes mellitus has been studied extensively [55]. Acet-
one, originating from the oral microbiota, most likely
contributes to the levels of acetone in breath to some
extent, and could hinder the usage of breath acetone as
a marker for diseases. It could also be one of the rea-
sons for the large variance in breath acetone levels
amongst different people. Acetone in the breath of
people with diabetesmellitus is considered to be a pro-
duct of poor glycemic control and to reﬂect the blood
acetone levels [55]. However, poor oral hygiene is also
strongly connected to poor glycemic control, with dia-
betic patients having threefold risk of severe oral dis-
eases [31]. Consequently, acetone in the breath of
diabetic patients could also partly originate from oral
bacteria, not only from the increased ketone body for-
mation. Acetone is considered hazardous in large
amounts (>500 ppm), however, the long-term effect
to gingival cells and oral cavity is not well known. In
ourmeasurement setup, P. gingivalis is capable of pro-
ducing acetone at the ppm level, and it is one of the
most abundantly produced compounds for all of the
studied bacteria. Although it is not a speciﬁc bio-
marker, acetone could be used in combination with
other compounds to discriminate between bacteria.
For example, all three P. gingivalis strains seem to pro-
duce high levels of both methanethiol and acetone,
whereas the other species produce both compounds at
signiﬁcantly lower levels. Thus, the combination of
acetone andmethanthiol could be used as an indicator
for the presence ofP. gingivalis.
Signals at m/z 57, 71, 87, 91, 95, 101, and 118 are
produced by compounds, whose identity is more difﬁ-
cult to determine. Several potential compounds could
be responsible for the signals, for example: butene and
acrolein for m/z 57; diacetyl, methylbutenol, penta-
none and methyl butanal for m/z 87; butanethiol,
methylthiourea and tropylium ion for m/z 91; phenol
and dimethyl disulphide for m/z 95; hexanal, methyl
isobutyl ketone, gamma-valerolactone and acet-
ylacetone for m/z 101; indole and benzyl cyanide for
m/z 118. Several of these compounds have been identi-
ﬁed in earlier studies as products of certain bacteria,
but it is difﬁcult to say without further analysis, which
of these compounds are responsible for the signals in
our measurements. However, the biological functions
of some of these compounds are better known than
others, which could indicate that these compounds are
more likely something that bacteria could emit.
The signal at m/z 57 could originate from butene
(C4H8), acrolein (prop-2-enal, C3H4O) or some frag-
ment ion (for example C4H9
+). In a GC-MS study,
butene was identiﬁed as a product of Pseudomonas
fragi [56]. It is most likely a degradation by-product of
more complex compounds. Acrolein, on the other
hand, has been connected to themicrobiota of the gas-
trointestinal track [57]. Few studies have been pub-
lished about the bacterial production of these
compounds, and consequently, their biological func-
tions in bacteria are unknown. Butene is regarded as a
nontoxic substance, but studies investigating the cyto-
toxicity of long-term exposure to this volatile are
sparse. Acrolein is considered harmful and capable of
producing direct tissue damage and irritation. It has
also been suggested to be carcinogenic and cytotoxic
even in small amounts [57]. In this study, P. gingivalis
produced the compound responsible for the signal at
m/z 57 in levels surpassing the acrolein odour detec-
tion limit, and most of the other bacteria also came
close. Another possible origin for the signal atm/z 57 is
a fragment or a cluster ion. Strong correlation
(R>0.90) between the signal atm/z 57 and several of
the other major signals recorded, could indicate the
presence of a fragment ion. Overall, the signal at m/z
57 is produced abundantly by all of the studied bac-
teria, and therefore, it could prove to be a valuable bio-
marker. Furthermore, if this compound is acrolein, its
toxicity to gingival cells and the oral cavity should be
studied. It is also possible that a large portion of this
signal originates from fragment ions, which should be
investigated in detail in the future.
All of the studied bacteria produce the compound
responsible for the signal at m/z 71 abundantly. It is
also one of the only compounds T. forsythia produces
in comparable amounts to the other bacteria. Accord-
ing to reference spectra and literature, this signal is
most likely produced by either pentene (C5H10) or
methylbutene (C5H10). Methylbutene, also known as
isopentene, is a branched isomer of pentene, and
therefore, it is difﬁcult to further distinguish between
them without additional structural analysis. The bio-
logical functions of these compounds are unclear.
However, earlier studies suggest 1-pentene and
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2-pentene as products of H. pylori and some soil bac-
teria [58, 59], and 2-methyl-1-butene as a product of
Pseudomonas ﬂuorescens SBW25 [60]. As mentioned
earlier, simple hydrocarbons are often degradation by-
products of more complex molecules, which could
also be the case for the signal at m/z 71. Production
proﬁles of this compound differ signiﬁcantly between
the studied bacterial species, with P. nigrescens and
P. intermedia being the largest producers, followed by
T. forsythia. For these bacterial species, the production
ofm/z 71 seems to be strongly connected to the active
growth, with the production increasing with increas-
ing amount of bacteria. It should be noted that T. for-
sythia grows slower than the other bacteria, requiring
about a week to reach active growth. The production
of m/z 71 by P. gingivalis is very different from the
other three bacteria, with consistent production dur-
ing the whole life cycle of the bacteria. Furthermore,
the early production levels of all the bacteria are simi-
lar, but differ signiﬁcantly from the empty agar back-
ground. P. gingivalis seems to be the only species to
stay on the same production level throughout the
measurements, whereas for the other three species, the
production is signiﬁcantly increased in the log phase.
This might suggest that a portion of the compound
responsible for the signal atm/z 71, originates from the
nutrient agar, but only in the presence of bacteria. For
P. gingivalis, the production might remain constant
because the bacteria itself does not produce additional
m/z 71, but rather converts the agar nutrient into this
compound. P. nigrescens, P. intermedia, and T. for-
sythia, on the other hand, produce additional levels of
this compound. Consequently, the signal at m/z 71
could distinguish P. nigrescens, P. intermedia and
T. forsythia from P. gingivalis, and therefore, it could be
a promising biomarker for these bacteria. These ﬁnd-
ings indicate a difference in themetabolic routes of the
studied bacteria.
The signal at m/z 87 could originate from several
different compounds, such as diacetyl (butane-2,3-
dione, C4H6O2), methylbutenol ((2E)-2-penten-2-ol,
C5H10O), pentanone (C5H10O), methyl isopropyl
ketone (MIPK, 3-methylbutan-2-one, C5H10O) and
methylbutanal (C5H10O). It is impossible to identify
the compound responsible for this signal without fur-
ther analysis. However, several previous studies have
identiﬁed diacetyl as a bacterial volatile [44, 61, 62],
although not from oral bacteria. The signal atm/z 87 is
not produced in large amounts by P. gingivalis strains,
but rather by P. nigrescens and P. intermedia. Out of
these two, P. nigrescens produces signiﬁcantly more of
this compound than P. intermedia, which is interesting
considering that these bacterial species are very similar
in many other aspects and produce other VOCs in
comparable amounts. Differences in the volatile ﬁn-
gerprints of these bacteria suggest divergence in their
metabolisms and could partly explain their different
roles in the pathogenesis of periodontitis. According
to our results, all of the studied bacteria produce the
compound responsible for the signal atm/z 87 in levels
higher than the recommended exposure limit for dia-
cetyl. If this compound proves to be diacetyl, the pro-
duction of P. nigrescens is especially alarming, since its
maximum production capacity is nearly 100 times the
recommended long-term limit. The possible role of
oral infections in the pathogenesis of respiratory dis-
eases has been debated strongly in recent decades, with
contradictory results [63]. However, bacterial volatiles
could be one of the keys connecting these diseases.
Considering the evidence of diacetyl as a cause for lung
disease [64], it is possible that high amounts produced
by oral bacteria could contribute to the development
of this condition. The biological functions of methyl-
butanal, MIPK, methylbutenol and pentanone are less
clear. Most of these compounds have been reported as
products of soil and plant bacteria, as well as, bacteria
related to fermentation [44]. The compound respon-
sible for the signal atm/z 87 is produced abundantly by
most of the studied bacteria, and therefore, it seems to
be an important marker especially for P. nigrescens.
Further conﬁrmation of the identity of this signal is
essential.
The signal atm/z 91 could also originate from sev-
eral different compounds, such as butanethiol/methyl
propyl sulﬁde (C4H10S), butanediol (C4H10O2),
methylthioacetate (S-methyl ethanethioate, C3H6OS)
or tropylium ion (C7H7
+). In addition to tropylium
ion, some other structurally different fragment ions
with the formula C7H7
+ could also be responsible for
the signal. These type of fragment ions are known pro-
ducts of many monoterpenes. However, there is no
evidence of monoterpene production by the studied
oral bacteria, as mentioned earlier. Tropylium ion, on
the other hand, is a common fragment product of
compounds containing a benzyl group. Compounds
such as benzyl cyanide (possible origin of m/z 118)
could consequently be the parent compound for the
tropylium ion and the signal atm/z 91. However, there
is no correlation between these two signals. On the
other hand, the tropylium ion could be a product of a
benzyl-containing compound that is not volatile, and
therefore, is not found from the volatile ﬁngerprints of
the bacteria. Isotope patterns in the reference spectra
suggest that the signal atm/z 91 originates more likely
from a compound with the formula C4H10S, com-
pared to butanediol or methylthioacetate. However,
all of these compounds, despite methyl propyl sulﬁde,
have been previously reported as volatile products of
bacteria [44]. In a GC/GC-TOF-MS study, Clos-
tridium difﬁcile was proven to produce butanethiol
[65]. In another study, C. difﬁcile was reported to pro-
duce methylthioacetate [66]. However, this result was
obtained with PTR-TOF-MS and identiﬁcation was
not veriﬁed. It is possible that the signal assumed to be
methylthioacetate was actually butanethiol as in the
GC/GC-TOF-MS study. The biological function of
butanethiol is unknown. Butanediol, on the other
hand, is known to be a product of several plant
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bacteria, and its production has been linked to the
induced growth and systemic resistance of plants. Sev-
eral rhizobacteria produce 2, 3-butanediol to trigger
defence mechanisms in plants to ﬁght against patho-
genic species [67]. Methylthioacetate has also been
reported to be a product of several plant and soil bac-
terial species [44, 48], however, its biological functions
are unclear. It has been suggested that methylthioace-
tate could be a growth-stimulating compound used in
the interaction between different bacterial species
[68]. Methyl propyl sulﬁde has not been measured
from bacteria, although, it is a known component of
human exhaled breath [69].
The signal atm/z 95 is most likely caused either by
phenol (C6H6O) or dimethyl disulﬁde (DMDS,
C2H6S2). Phenol has been connected in earlier studies
to several bacterial species [44, 70], but its biological
functions are unclear. Phenol is a toxic substance, and
its production could be connected to competition
between bacterial species. Phenolic compounds are
widespread in nature. Phenol emitted by bacteria
could be a degradation by-product of more complex
phenolic compounds. It could also contribute to the
virulence of the bacteria capable of producing it.
DMDS, on the other hand, has been identiﬁed as a
product of multiple different bacteria, especially those
related to soil environments. Several bacteria living
in the gastrointestinal system also produce DMDS,
and it has also been identiﬁed as a product of bacteria
present in the oral cavity and the respiratory tract
[16, 40, 41, 44]. Similarly to other sulphur containing
compounds produced by oral bacteria, DMDS is con-
nected to halitosis and malodour. Concentrations of
DMDS in the human exhaled breath range between 0
and 3 ppb [9]. Concentrations of DMDS measured
from other pathogenic bacteria, including S. aureus, P.
aeruginosa, S. pneumoniae and H. inﬂuenza, range
from a few ppbs to about 10 ppb [40, 41]. DMDS is
considered harmful only in large amounts (>50 ppm),
however, the garlic-like odour can be detected by
humans at about 10 ppb. In our study, all three P. gin-
givalis strains produced signal at m/z 95 in levels
around 30 ppb, and in similar amounts. The other
bacterial species produce signiﬁcantly lower levels
of this compound, and P. intermedia none. Conse-
quently, the compound responsible for the signal at
m/z 95 could be one of themost promising biomarkers
speciﬁcally for P. gingivalis. It can be observed from
the dynamic production proﬁles that the maxima of
them/z 95 production happen at a later time-point in
the bacterial life cycle. This might indicate that the
compound responsible for the signal at m/z 95 is
released mostly in the death phase and is perhaps a
compound related to stress response. If phenol is the
compound responsible for this signal, the long-term
exposure of the oral cavity to this microbial toxin has
to be addressed in the future. However, as the produc-
tion of DMDS by oral bacteria has been reported ear-
lier and the volatile sulphur containing compounds
seem to be major metabolites for these bacteria, it is
more likely that the signal at m/z 95 originates from
DMDS. Inspection of the isotope patterns in the refer-
ence spectra supports this as well.
The signal at m/z 101 could be due to several
different compounds, such as hexanal (C6H12O),
methyl isobutyl ketone (4-methylpentan-2-one,
C6H12O) gamma-valerolactone (5-methyloxolan-2-
one, C5H8O2), and acetylacetone (pentane-2,4-dione,
C5H8O2). Identiﬁcation of this signal is impossible
without further analysis. Gamma-valerolactone has
been identiﬁed as a product of several soil and marine
related bacterial species [44, 68], although, its biologi-
cal role is unknown. More complex acyl-homoserine
lactones have been connected to bacterial quorum
sensing [71]. Several other lactones, such as phtha-
lides, have a distinct odour of vegetables and herbs.
These volatile, odour-producing compounds could
well be something oral bacteria produce, and gamma-
valerolactone could be a breakdown product of these
more complex compounds. Acetylacetone produc-
tion, on the other hand, has been connected to several
plant and soil bacteria, and it could be connected to
both bacterial interaction and growth protomotion
[68]. Hexanal has been identiﬁed as a product of sev-
eral bacterial species connected to meat spoilage [56].
It is thought to be a product of hydrolysis of triglycer-
ides or degradation of amino acids. The compound
responsible for the signal at m/z 101 is produced in
similar, small amounts by all of the studied bacteria.
The production of this compound is consistent
throughout the life-cycle of the bacteria, which might
result from the bacteria converting a nutrient from the
agar to a volatile form. However, the production max-
ima of the signal at m/z 101 are located at the late sta-
tionary and death phase of the bacteria, which
indicates that it is not a compound related to the active
growth. Further identiﬁcation of this signal should be
done in the future, for example byGC-MSmethods.
Based on its vast biological functions, indole
(C8H7N) is the most likely origin of the signal at m/z
118. Another possibility is benzyl cyanide (phenylace-
tonitrile, C8H7N). Further identiﬁcation between
these structural isomers is impossible with the PTR-
MS method. Indole is a known metabolite of amino
acid tryptophan and has many known functions in
bacterial metabolism [44, 60, 62]. It has been con-
nected to bacterial virulence, cell cycle regulation, acid
resistance, signalling, quorum sensing, and bioﬁlm
formation. It also promotes bacterial excretion of tox-
ins, improves bacterial drug resistance, and regulates
the genetic stability of bacteria, for example by mana-
ging the maintenance of plasmids copies. There is also
evidence of indole regulating the stress response of
bacteria and stimulating growth. Indole is widespread
in the natural environment and several human patho-
genic bacteria have been shown to produce it in large
amounts [58, 61, 62]. In addition, indole has a strong
odour and it has been connected to halitosis. It exists
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in the human exhaled breath in levels less than 1 ppb
[9]. On the contrary, biological functions of benzyl
cyanide are mostly unknown, and only a few bacteria
are known to produce it [72]. It is not considered
harmful itself, however, its major breakdown product
hydrogen cyanide (HCN) is highly toxic. It has been
reported earlier that several of the oral bacteria studied
in this article can produce HCN [18]. However,
because of its biological role and many earlier reports
of production by bacteria, it is more likely that the sig-
nal atm/z 118 originates from indole. The signal atm/z
118 is produced abundantly by all the bacterial species
studied, except for T. forsythia, which produces it only
slightly above the background level. All the other bac-
teria produce this compound in similar amounts,
which indicates its importance to these species. As
indole has been connected to bioﬁlm formation, the
lower indole levels produced by T. forsythia could
indicate distinct bioﬁlm formation mechanism from
the other bacteria. P. gingivalis, P. intermedia, and P.
nigrescens readily form bioﬁlms and adhere to surfaces
and other bacteria. However, the virulence factors and
bioﬁlm formation mechanisms of T. forsythia are less
known. The monospecies bioﬁlm formation of T. for-
sythia is poor, but it has been shown that it produces
mixed synergistic bioﬁlms with F. nucleatum [73]. The
virulence factors of T. forsythia are also known to be
enhanced, when coexisting with other oral bacteria.
N-acetyl muramic acid (NAM) is an important amino
sugar essential for the formation of the peptidoglycan
cell wall of bacteria. Unlike the other oral bacteria, T.
forsythia lacks a metabolic pathway to synthesize its
own NAM, and therefore, has to harvest it from the
degradation products of the oral bioﬁlm. This further
suggests the importance of co-colonization to T. for-
sythia. It has also been shown that T. forsythia readily
co-aggregates with other bacteria, facilitating oral bio-
ﬁlm formation [73]. Often bacteria habiting the same
microenvironment take on different functions from
each other to adapt better to their shared niche.
Although, there are only a few studies explaining the
precise relationship between the red complex species,
differences in the volatile proﬁles of these bacteria
could be an indicator of different function in their
niche. In future studies, we aim to investigate the vola-
tile proﬁles of bacteria inmixed culture, which is espe-
cially important considering T. forsythia. It would be
interesting to see, whether the volatile ﬁngerprints
change in the presence of other bacteria and how those
changes could be connected for example to the bioﬁlm
formation or bacterial signalling.
5. Limitations
There are some remaining issues we wish to address.
We acknowledge that one of the main limitations of
our current study, is the lack of information about the
growth rate of the bacterial cultures. In our agar-based
model, with combined real time headspace analysis, it
is challenging to determine the growth rate of the
cultures. This would require us to scrape the bacteria
off the plate, and hence, lose our VOC analysis sample.
It is possible to have a different set of cultures growing
in the same conditions as those used for the VOC
analysis, and those could then be scraped at different
time points. This would allow us to determine the
growth rate of the reference culture, and thus the
growth rate of our culture model could be approxi-
mated. This method would not, however, allow us to
measure the exact growth rate of the culture under
VOC analysis. We plan to utilize the preliminary
results gained from this study in the next stages of our
research, wherewe aim to improve our in vitromodel.
The properties of the bioﬁlms produced in our
agar-based closed culture system are not ideal or com-
parable with in vivo bioﬁlms. In the future, we plan to
reproduce the VOC measurements described in this
article with broth cultures, for comparison. Many ear-
lier studies have measured VOC productions from
broth-based closed cultures [17, 19, 40, 48, 49, 61, 65].
The determination of growth rate from broth cultures
is easy, and they provide simplermeans to studymixed
cultures and the effect of nutrient compositions.Mod-
els that more accurately represent the in vivo condi-
tions of the oral cavity, e.g. substrate availability,
salivary ﬂow and different colonization surfaces, are
based on continuous culture systems. In these, fresh
medium is continuously added to the bacterial cul-
tures and waste products are continuously removed.
In the future, we will also consider using a ﬁlter or ﬂow
cell based continuous bioﬁlmmodel [16, 74].
6. Conclusions
Abundant levels ofmethane thiol (m/z 49) and acetone
(m/z 59) seem to be themajormarkers for P. gingivalis,
regardless of the strain. Other important markers for
P. gingvalis are m/z 95 (DMDS or phenol) and m/z 57
(butene or acrolein). Largest differences between
P. gingivalis strains were measured for m/z 57 and
isoprene (m/z 69). For the most part, P. gingivalis
strains OMG 434 and W50 seem to have more similar
volatile production proﬁles compared to ATCC
33277. Analysis of the methanethiol levels in human
exhaled breath could be a possible future diagnostic
tool for identifying P. gingivalis in the oral cavity, if
contribution from the lower respiratory tract and
other sources can be assessed or eliminated.
P. nigrescens seems to produce volatiles more
abundantly than P. intermedia, withm/z 49, 69, 87, 63
and 91 being the most distinct signals between them.
The signals atm/z 87 (pentanone, methyl butanal, dia-
cetyl, methyl butenol) and isoprene (m/z 69) seem to
be the distinctive compounds separating P. intermedia
and P. nigrescens from P. gingivalis. Lower levels of
methanethiol and acetone than those produced by P.
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gingivalis, and elevated levels of isoprene and m/z 87,
could be indicators forP. intermedia andP. nigrescens.
T. forsythia produces fewer volatile compounds
and at signiﬁcantly lower levels than all of the other
species studied. T. forsythia produced only signals at
m/z 49, 57, 71, 101 and 118 in levels higher than the
empty agar plate. Only signals at m/z 71 and 101 were
produced in similar levels to some of the other bac-
teria. All other emissions were signiﬁcantly lower.
Measurements with mixed cultures could prove to be
especially important for T. forsythia, because of its co-
operative requirements, and its volatile ﬁngerprint
might be signiﬁcantly different in those conditions.
Identiﬁcation of the unknown signals, as well as,
conﬁrmation of the tentatively identiﬁed compounds,
should be performed in the future by GC-MS or
another suitable method. Since tissue destruction is a
major complication of some oral infections, it is also
essential to knowmore about the effects of toxic com-
pounds, such as methanethiol, to oral tissues. Con-
tinuous, low level exposure to these toxic volatiles
produced by oral bacteria could be one of the major
causes of both minor and serious issues in oral health.
In the next stage of our research, we aim to continue
the identiﬁcation of the compounds found in this
study, and also to extend our measurements to other
oral bacterial species. It is especially important to
move from the highly idealized conditions of the
monocultures towards conditions more representa-
tive of the actual oral cavity. In addition to the in vitro
measurements, we aim to connect the bacterial ﬁnd-
ings to the volatile ﬁngerprints of human exhaled
breath in vivo.
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